CHARLES KIM v. SYK BIOSCIENCES LLC & Others.

CourtMassachusetts Appeals Court
DecidedApril 15, 2026
Docket25-P-0616
StatusUnpublished

This text of CHARLES KIM v. SYK BIOSCIENCES LLC & Others. (CHARLES KIM v. SYK BIOSCIENCES LLC & Others.) is published on Counsel Stack Legal Research, covering Massachusetts Appeals Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
CHARLES KIM v. SYK BIOSCIENCES LLC & Others., (Mass. Ct. App. 2026).

Opinion

NOTICE: Summary decisions issued by the Appeals Court pursuant to M.A.C. Rule 23.0, as appearing in 97 Mass. App. Ct. 1017 (2020) (formerly known as rule 1:28, as amended by 73 Mass. App. Ct. 1001 [2009]), are primarily directed to the parties and, therefore, may not fully address the facts of the case or the panel's decisional rationale. Moreover, such decisions are not circulated to the entire court and, therefore, represent only the views of the panel that decided the case. A summary decision pursuant to rule 23.0 or rule 1:28 issued after February 25, 2008, may be cited for its persuasive value but, because of the limitations noted above, not as binding precedent. See Chace v. Curran, 71 Mass. App. Ct. 258, 260 n.4 (2008).

COMMONWEALTH OF MASSACHUSETTS

APPEALS COURT

25-P-616

CHARLES KIM

vs.

SYK BIOSCIENCES LLC & others.1

MEMORANDUM AND ORDER PURSUANT TO RULE 23.0

The plaintiff, Dr. Charles Kim, appeals from a Superior

Court judgment dismissing his eight-count complaint on the

ground that the forum selection clauses (FSCs) in his employment

agreements with the defendants SYK Biosciences LLC (SYK) and

Pulsethera, Inc. (P-Inc.) require the case to be filed in

Delaware. On appeal, Kim argues that the FSCs do not apply to

all of his claims or to those defendants who are not parties to

his agreements with SYK and P-Inc. We vacate so much of the

judgment as dismissed Kim's Massachusetts statutory claims, but

we otherwise affirm the judgment.

1Pulsethera Corp., Pulsethera, Inc., Leon Frances Hebert, Jr., Michael Mansour, Ji-Xin Cheng, and Steven Qian. Background. We recite certain essential facts as alleged

in Kim's verified first amended complaint (the operative

complaint). Kim is a chemist and scientist living in Boston.

The defendant SYK was a startup biotechnology company that

operated in Boston until its dissolution in 2023, and the

defendants Leon F. Hebert, Jr., and Michael Mansour are

Massachusetts residents who are principals of SYK and who

exercised significant managerial control over SYK at all

relevant times. The defendants P-Inc. and Pulsethera Corp. (P-

Corp.) are startup medical device companies based in Boston.

The defendants Ji-Xin Cheng and Steven Qian are Massachusetts

residents who, along with Hebert and Mansour, are principals of

P-Corp. and exercised significant managerial control over P-

Corp. at all relevant times. The complaint often refers to P-

Inc. and P-Corp. collectively and interchangeably as

"Pulsethera," and we do the same, except where necessary to

distinguish one from the other.

1. SYK agreement. On December 8, 2021, Kim signed a

"consulting agreement" with SYK to work as a scientist. The SYK

agreement was for a term of twelve months, "unless there is an

earlier termination or extension as provided herein," but it did

not include any further provision regarding extensions. The SYK

agreement provided for payment to Kim at a rate of $200 per hour

2 plus expenses, contained an acknowledgment that he was an

independent contractor, and included a Delaware choice of law

clause and an FSC providing that "any dispute under this

[a]greement that cannot be settled by the [p]arties shall be

decided in the [F]ederal or a [S]tate court of the State of

Delaware."

In November 2022, Kim reminded Hebert that the SYK

agreement would be expiring soon and requested an extension.

Hebert stated that he would send paperwork to extend the

agreement, but he did not do so. Kim alleges that the SYK

agreement expired on December 8, 2022. Later that December, Kim

again asked Hebert to extend the SYK agreement, and to backdate

the extension to account for work Kim had done since the

expiration. Once again, Hebert did not do so, and so in

February 2023, Kim asked Hebert and Mansour to "sign a follow-on

contract for SYK that covers work from December 9, 2022 and

onward. This would cover the work we've been doing to prepare

formulations for the baboon studies." Once again, no extension

paperwork was sent. At least as to the work he performed in

December 2022, Kim alleges that he made the "reasonable

assumption that his work for the [d]efendant companies would be

paid at the rate of $200 per hour, as provided by, inter alia,

the [a]greements." Further, SYK, Hebert, and Mansour knew that

3 Kim continued to perform work for SYK following the agreement's

expiration date.

SYK did not pay Kim for the work he did between November

2022 and February 2023 -- including thirty-seven hours before

the asserted expiration date and fifty-nine and one-half hours

after that date -- and did not reimburse him for a software

expense he incurred after the expiration date. In an exchange

of electronic mail messages in February and March 2023, Hebert

acknowledged the delay in paying Kim "the amount due," and

stated that he (Hebert) would speak or had spoken to his

investor in an effort to obtain payment to Kim, but the payments

were never made.

2. P-Inc. agreement. In the meantime, on September 23,

2022, after discussions with Hebert and Mansour, Kim had signed

an agreement with P-Inc. to work as a scientist, on terms

essentially identical to those in the SYK agreement. The P-Inc.

agreement also included a choice of law clause and an FSC

identical to those in the SYK agreement. Despite P-Inc.'s being

the agreement's signatory, Kim alleges that he was working for

both P-Inc. and P-Corp. -- i.e., that they were his "joint

employers" -- because the sole payment he received from either

entity was from P-Corp. He asserts that the two entities were

indifferent to maintaining any material distinction between

4 themselves. Kim received no payment for the work he performed

for Pulsethera from December 7-31, 2022.

3. The claims. The operative complaint asserted eight

claims, four of which were asserted against all defendants.

Count one claimed that Kim was an employee but was misclassified

as an independent contractor in violation of G. L. c. 149,

§ 148B. Count two claimed violations of the Wage Act, G. L.

c. 149, § 148. Count three asserted a quantum meruit claim and

count four asserted an unjust enrichment claim; both counts

focused on the defendants' failure to pay Kim for the work he

performed.

Of the remaining claims, count five asserted that

Pulsethera, Hebert, and Mansour, despite never intending to pay

Kim for work he would do for Pulsethera, fraudulently induced

Kim to enter the P-Inc. agreement and to perform such work.

Count six asserted that SYK, Pulsethera, Hebert, and Mansour,

while both agreements were in effect, made false and misleading

statements to Kim regarding their intention to pay him for the

work he was doing for SYK and Pulsethera. Count seven asserted

a promissory estoppel claim against SYK, Pulsethera, Hebert, and

Mansour, alleging that Kim performed work for them in reasonable

reliance on their promises to pay him. Finally, count eight

asserted a conspiracy claim against all defendants, alleging an

5 unlawful combination to (among other things) obtain Kim's work

without paying him. Notably, Kim did not assert any breach of

contract claims.2

On the defendants' motion to dismiss under Mass. R. Civ. P.

12 (b) (6), 365 Mass.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ashall Homes Ltd. v. ROK Entertainment Group Inc.
992 A.2d 1239 (Court of Chancery of Delaware, 2010)
Adoption of Mary
610 N.E.2d 898 (Massachusetts Supreme Judicial Court, 1993)
Ingres Corp. v. CA, INC.
8 A.3d 1143 (Supreme Court of Delaware, 2010)
Machado v. System4 LLC
471 Mass. 204 (Massachusetts Supreme Judicial Court, 2015)
National Industries Group v. Carlyle Investment Management L.L.C.
67 A.3d 373 (Supreme Court of Delaware, 2013)
Gabbidon v. King
414 Mass. 685 (Massachusetts Supreme Judicial Court, 1993)
Jacobson v. Mailboxes Etc. U.S.A., Inc.
419 Mass. 572 (Massachusetts Supreme Judicial Court, 1995)
Carey v. New England Organ Bank
446 Mass. 270 (Massachusetts Supreme Judicial Court, 2006)
Bay State Gas Co. v. Department of Public Utilities
947 N.E.2d 1077 (Massachusetts Supreme Judicial Court, 2011)
Melia v. Zenhire, Inc.
967 N.E.2d 580 (Massachusetts Supreme Judicial Court, 2012)
Casavant v. Norwegian Cruise Line, Ltd.
829 N.E.2d 1171 (Massachusetts Appeals Court, 2005)
Chace v. Curran
881 N.E.2d 792 (Massachusetts Appeals Court, 2008)
Baby Furniture Warehouse Store, Inc. v. Meubles D&F Ltée
911 N.E.2d 800 (Massachusetts Appeals Court, 2009)
Dixon v. Perry & Slesnick, P.C.
914 N.E.2d 97 (Massachusetts Appeals Court, 2009)
Boland v. George S. May International Co.
969 N.E.2d 166 (Massachusetts Appeals Court, 2012)
Ajemian v. Yahoo!, Inc.
987 N.E.2d 604 (Massachusetts Appeals Court, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
CHARLES KIM v. SYK BIOSCIENCES LLC & Others., Counsel Stack Legal Research, https://law.counselstack.com/opinion/charles-kim-v-syk-biosciences-llc-others-massappct-2026.